Related Experiment Video
Updated: Jan 4, 2026

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
Published on: May 6, 2015
Hif1a and Hif2a can be safely inactivated in cone photoreceptors
Marijana Samardzija1, Maya Barben2, Vyara Todorova2
1Lab for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, Schlieren, CH-8952, Switzerland. marijana.samardzija@usz.uzh.ch.
Abstract:
Impaired tissue oxygenation results in hypoxia and leads to the activation of hypoxia-inducible transcription factors (HIF). A chronic, HIF-triggered molecular response to hypoxia may be an important factor in the etiology of age-related macular degeneration (AMD) and is likely activated before any clinical manifestation of the disease. Thus, HIF1 and HIF2 recently emerged as potential therapeutic targets for AMD. To address and evaluate potential consequences of anti-HIF therapies for retinal physiology and function, we generated mouse lines that have Hif1a, or both Hif1a and Hif2a ablated specifically in cone photoreceptors. The knockdown of Hifs in cones did not cause detectable pathological alterations such as loss of cone photoreceptors, retinal degeneration or abnormalities of the retinal vasculature, had no impact on retinal function and resulted in a similar tolerance to hypoxic exposure. Our data indicate that HIF transcription factors are dispensable for maintaining normal cone function and survival in retinas of adult mice. This study provides the groundwork necessary to establish safety profiles for strategies aiming at antagonizing HIF1A and HIF2A function in cone photoreceptors for the treatment of retinal degenerative diseases that involve a hypoxic component such as AMD.
Insights
Hypoxia-inducible factors (HIFs) are implicated in age-related macular degeneration (AMD). Ablating HIFs in cone photoreceptors did not harm retinal function or survival, suggesting potential safety for anti-HIF therapies in AMD treatment.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Impaired tissue oxygenation causes hypoxia, activating hypoxia-inducible transcription factors (HIFs).
- Chronic HIF activation is a potential factor in age-related macular degeneration (AMD) etiology.
- HIF1 and HIF2 are emerging therapeutic targets for AMD.
Purpose of the Study:
- To evaluate the consequences of anti-HIF therapies on retinal physiology and function.
- To assess the role of HIFs in cone photoreceptors for potential AMD treatments.
Main Methods:
- Generated mouse lines with Hif1a or both Hif1a and Hif2a ablated specifically in cone photoreceptors.
- Assessed pathological alterations, retinal function, and hypoxic tolerance in these mouse lines.
Main Results:
- HIF ablation in cone photoreceptors did not cause photoreceptor loss, retinal degeneration, or vascular abnormalities.
- Retinal function remained unaffected, and hypoxic tolerance was similar to control mice.
- HIF transcription factors are dispensable for normal cone function and survival in adult mouse retinas.
Conclusions:
- HIFs are not essential for maintaining cone photoreceptor function and survival in adult mice.
- This study provides foundational safety data for anti-HIF therapies targeting cone photoreceptors.
- These findings support strategies for treating hypoxic retinal degenerative diseases like AMD by antagonizing HIF1A and HIF2A.
Related Concept Videos
Photoreceptors and Visual Pathways
The Retina
Anatomy of the Eyeball
Regulation of Angiogenesis and Blood Supply
Unrenewable Cells
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

